News

Juniper Pharma Services expands granulation capabilities

7 months ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services. The UK-based contract development and manufacturing organisation (CDMO) has purchased a Gerteis MINI-PACTOR® to expand its granulation capabilities and

Webinar – An Integrated Bio-Pharmaceutics Approach For Effective Drug Development

8 months ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development at 3.00pm – 4.00pm (BST) on Thursday 8th September 2016. The webinar will examine why new drug candidates fail during development for many reasons, and will be centred around: Undesirable absorption and/or metabolism of the compound in man

Tablet press investment at Juniper Pharma Services

10 months ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has bolstered its tablet manufacturing capabilities following the purchase and validation of an additional tablet press. The investment by the UK-based contract development and manufacturing organisation (CDMO) significantly extends its tablet production capacity and further strengthens the company’s ability

Juniper Pharma Services strengthens topicals capability

12 months ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage topical and semi-solids capability by investing in a Becomix homogenizer mixer. The installation and validation of the new equipment extends the company’s ability to manufacture creams, ointments, and semi-solids to support clients’ clinical trial

Juniper Pharma Services scales up spray-drying capability

12 months ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its enabling technologies platform by making a substantial investment into its spray drying capabilities. The contract development and manufacturing organisation (CDMO) has placed an order for a PSD-1 spray dryer, which is manufactured by GEA Niro and

Juniper Pharma Services and XenoGesis to head to Barcelona on market visit

1 year ago

Juniper Pharma Services is joining forces with XenoGesis on a market visit to Barcelona this March. The visit, which is being supported by UKTI, will include a tour of a number of life science companies in the Barcelona area. Juniper Pharma Services and XenoGesis have been working together to offer a seamless and combined service to clients

Juniper and Crystec sign agreement for next generation medicines

1 year ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), will work with CrystecPharma on a major multi-partner project as part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) to help create a new platform to accelerate drug development in the future. Both companies will collaborate as part of this UK-based

Juniper Pharma Services strengthens capsule capability with Xcelodose

1 year ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabilities. The move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to

Demonstrating Therapeutic Equivalence for Generic Topical Products

1 year ago

Our Chief Technical Officer, Rob Harris discusses how the determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation in this article as featured in Pharmaceutical Technology entitled ‘Demonstrating Therapeutic Equivalence for Generic Topical Products’. You can read full article online via PharmTech.com.

Delegates are shown around the lab at Juniper Pharma Services

2 years ago

Businesses from one of China’s biggest international trading cities have held talks with life sciences and healthcare firms from Nottingham during a tour of the city. The delegation from Ningbo – the fifth-biggest container port in the world – has been exploring commercial links with Nottingham as part of a wider push to grow trade